Short answer
TG THERAPEUTICS, INC. (TGTX) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 earnings results disclosed; period ended December 31, 2025.
TG THERAPEUTICS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings results disclosed; period ended December 31, 2025
- Full financials in Exhibit 99.1 press release: key figures not included in this filing item
- TGTX report covers period reflecting BRIUMVI commercial ramp; revenue trajectory key investor focus
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TG THERAPEUTICS, INC. 8-K filings
Get the next TGTX 8-K as it lands
Follow TGTX for push alerts, or ask the research agent what this filing means.